# NIFEDIPINE
> **ANDA216019** · Abbreviated New Drug Application (Generic) · Sponsor: PHARMADAX · Approved 2022-11-18
## Drug
- **FDA Application Number:** ANDA216019
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** NIFEDIPINE
- **Generic name:** Nifedipine
- **Active ingredients:** NIFEDIPINE
- **Dosage form:** TABLET, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** PHARMADAX
- **First approval:** 2022-11-18
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216019)
---
*AI Analytics · CC0 1.0*